Abstract
Background
Screening for hepatocellular carcinoma (HCC) has been shown to improve survival via earlier cancer detection. Although HCC screening is considered standard of care in the USA, little is known of the adherence to this practice, especially in a community setting.
Aims
Our primary goal was to evaluate adherence to HCC screening and to find predictors of screening adherence in a community setting. Our secondary objective was to determine the impact of screening on survival.
Methods
We studied a cohort of 557 consecutive patients at high risk for HCC: patients with cirrhosis and older chronic hepatitis B (CHB) patients without cirrhosis (≥45 years old). Patients initiated screening 1/2001–1/2005 and were monitored ≥12 months to 12/2008 in two community gastroenterology clinics in Northern California. HCC screening was categorized into four groups based on combined frequency of serum alpha-fetoprotein and imaging: optimal, suboptimal, poor, and no screening.
Results
About 40.6% of our cohort received poor or no screening. Noncirrhotic CHB patients had worse screening than cirrhotic patients. Multivariate analysis revealed that patients with a greater number of clinical visits per year were 3.4 times more likely to have regular screening than patients with fewer clinical visits per year (P < 0.001). There was a trend for association between HCC screening and greater access to curative treatment.
Conclusion
Since more frequent clinic visits is a strong independent predictor of improved screening adherence, regular routine clinic visits may help improve adherence to HCC screening, which may also lead to improved clinical outcomes.
Similar content being viewed by others
Abbreviations
- HCC:
-
Hepatocellular carcinoma
- CHB:
-
Chronic hepatitis B
- HBV:
-
Hepatitis B virus
- HCV:
-
Hepatitis C virus
- AFP:
-
Alpha-fetoprotein
- US:
-
Ultrasound
- AASLD:
-
American Association for the Study of Liver Diseases
- HMO:
-
Health maintenance organization
- PPO:
-
Preferred provider organization
- WBC:
-
White blood count
- HCT:
-
Hematocrit
- PLT:
-
Platelet count
- INR:
-
International normalized ratio
- CR:
-
Creatinine
- TB:
-
Total bilirubin
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- ALK:
-
Alkaline phosphatase
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
References
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.
El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27–S34.
McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:1198–1203.
National Cancer Institute. SEER cancer statistics review, liver and intrahepatic bile duct section. Available at http://seer.cancer.gov/csr/1975_2006/results_merged/sect_14_liver_bile.pdf. Accessed 21 Oct 2009.
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127:S35–S50.
Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129–1133.
McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25(Suppl 1):3–8.
Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000;31:1014–1018.
Marrero JA, Welling T. Modern diagnosis and management of hepatocellular carcinoma. Clin Liver Dis. 2009;13(2):233–247.
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.
Hwang JP, Hassan MM. Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation. BMC Cancer. 2009;9:46.
Nguyen MH, Keeffe EB. General management. Best Pract Res Clin Gastroenterol. 2005;19:161–174.
Stravitz RT, Heuman DM, Chand N, et al. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med. 2008;121:119–126.
Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol. 2007;102:1661–1670.
Chen JG, Parkin DM, Chen QG, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2003;10:204–209.
Yang B, Zhang B, Xu Y, et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol. 1997;123:357–360.
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417–422.
Early diagnosis of hepatocellular carcinoma in Italy. A summary of a consensus development conference held in Milan, 16 November 1990 by the Italian association for the study of the liver (AISF). J Hepatol. 1992;14:401–403.
Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001;35:421–430.
Colombo M. Screening for cancer in viral hepatitis. Clin Liver Dis. 2001;5:109–122.
Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol. 2002;35:S86–S91.
Nguyen TT, Gildengorin G, Truong A, McPhee SJ. Factors influencing physicians’ screening behavior for liver cancer among high-risk patients. J Gen Intern Med. 2007;22:523–526.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, C.R., Garcia, R.T., Trinh, H.N. et al. Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting. Dig Dis Sci 54, 2712–2721 (2009). https://doi.org/10.1007/s10620-009-1015-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-1015-x